vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($173.1M vs $138.3M, roughly 1.3× Core Laboratories Inc.). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs 5.3%, a 15.1% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (2.8% vs -0.2%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $5.1M). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (2.9% CAGR vs -18.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

CASH vs CLB — Head-to-Head

Bigger by revenue
CASH
CASH
1.3× larger
CASH
$173.1M
$138.3M
CLB
Growing faster (revenue YoY)
CLB
CLB
+3.0% gap
CLB
2.8%
-0.2%
CASH
Higher net margin
CASH
CASH
15.1% more per $
CASH
20.3%
5.3%
CLB
More free cash flow
CASH
CASH
$98.9M more FCF
CASH
$104.1M
$5.1M
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
2.9%
-18.0%
CASH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CASH
CASH
CLB
CLB
Revenue
$173.1M
$138.3M
Net Profit
$35.2M
$7.3M
Gross Margin
Operating Margin
24.6%
11.5%
Net Margin
20.3%
5.3%
Revenue YoY
-0.2%
2.8%
Net Profit YoY
11.9%
1.2%
EPS (diluted)
$1.57
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
CLB
CLB
Q1 26
$138.3M
Q4 25
$173.1M
$138.3M
Q3 25
$186.7M
$134.5M
Q2 25
$195.8M
$130.2M
Q1 25
$274.8M
$123.6M
Q4 24
$182.6M
$129.2M
Q3 24
$179.5M
$134.4M
Q2 24
$188.6M
$130.6M
Net Profit
CASH
CASH
CLB
CLB
Q1 26
$7.3M
Q4 25
$35.2M
$4.9M
Q3 25
$38.8M
$14.2M
Q2 25
$42.1M
$10.6M
Q1 25
$75.0M
$-154.0K
Q4 24
$30.0M
$7.4M
Q3 24
$33.5M
$11.7M
Q2 24
$44.9M
$9.0M
Gross Margin
CASH
CASH
CLB
CLB
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CASH
CASH
CLB
CLB
Q1 26
11.5%
Q4 25
24.6%
11.5%
Q3 25
25.9%
15.6%
Q2 25
24.1%
11.7%
Q1 25
33.2%
3.6%
Q4 24
19.8%
11.0%
Q3 24
20.9%
14.7%
Q2 24
27.1%
12.3%
Net Margin
CASH
CASH
CLB
CLB
Q1 26
5.3%
Q4 25
20.3%
3.6%
Q3 25
20.8%
10.6%
Q2 25
21.5%
8.2%
Q1 25
27.3%
-0.1%
Q4 24
16.4%
5.7%
Q3 24
18.7%
8.7%
Q2 24
23.8%
6.9%
EPS (diluted)
CASH
CASH
CLB
CLB
Q1 26
$0.16
Q4 25
$1.57
$0.11
Q3 25
$1.69
$0.30
Q2 25
$1.81
$0.22
Q1 25
$3.14
$0.00
Q4 24
$1.23
$0.15
Q3 24
$1.34
$0.25
Q2 24
$1.78
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$331.2M
$22.8M
Total DebtLower is stronger
$33.5M
Stockholders' EquityBook value
$854.5M
$279.8M
Total Assets
$7.6B
$597.0M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
CLB
CLB
Q1 26
$22.8M
Q4 25
$331.2M
$22.7M
Q3 25
$120.6M
$25.6M
Q2 25
$258.3M
$31.2M
Q1 25
$254.2M
$22.1M
Q4 24
$597.4M
$19.2M
Q3 24
$158.3M
$21.5M
Q2 24
$298.9M
$17.7M
Total Debt
CASH
CASH
CLB
CLB
Q1 26
Q4 25
$33.5M
$110.3M
Q3 25
$33.5M
$114.1M
Q2 25
$33.4M
$124.6M
Q1 25
$33.4M
$124.4M
Q4 24
$33.4M
$126.1M
Q3 24
$33.4M
$139.9M
Q2 24
$33.3M
$147.6M
Stockholders' Equity
CASH
CASH
CLB
CLB
Q1 26
$279.8M
Q4 25
$854.5M
$266.0M
Q3 25
$858.0M
$271.3M
Q2 25
$819.0M
$261.3M
Q1 25
$814.7M
$253.4M
Q4 24
$758.3M
$246.6M
Q3 24
$822.5M
$250.7M
Q2 24
$748.4M
$240.3M
Total Assets
CASH
CASH
CLB
CLB
Q1 26
$597.0M
Q4 25
$7.6B
$584.0M
Q3 25
$7.2B
$591.4M
Q2 25
$7.2B
$602.1M
Q1 25
$7.0B
$591.5M
Q4 24
$7.6B
$585.1M
Q3 24
$7.5B
$600.5M
Q2 24
$7.5B
$597.8M
Debt / Equity
CASH
CASH
CLB
CLB
Q1 26
Q4 25
0.04×
0.41×
Q3 25
0.04×
0.42×
Q2 25
0.04×
0.48×
Q1 25
0.04×
0.49×
Q4 24
0.04×
0.51×
Q3 24
0.04×
0.56×
Q2 24
0.04×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
CLB
CLB
Operating Cash FlowLast quarter
$108.3M
$37.2M
Free Cash FlowOCF − Capex
$104.1M
$5.1M
FCF MarginFCF / Revenue
60.1%
3.7%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
3.08×
5.12×
TTM Free Cash FlowTrailing 4 quarters
$616.8M
$27.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
CLB
CLB
Q1 26
$37.2M
Q4 25
$108.3M
$7.9M
Q3 25
$303.7M
$8.5M
Q2 25
$30.4M
$13.9M
Q1 25
$188.3M
$6.7M
Q4 24
$-71.7M
$20.6M
Q3 24
$143.1M
$13.1M
Q2 24
$113.2M
$17.1M
Free Cash Flow
CASH
CASH
CLB
CLB
Q1 26
$5.1M
Q4 25
$104.1M
$5.0M
Q3 25
$300.3M
$6.5M
Q2 25
$27.7M
$10.4M
Q1 25
$184.7M
$3.9M
Q4 24
$-73.8M
$17.4M
Q3 24
$138.8M
$10.4M
Q2 24
$111.0M
$14.3M
FCF Margin
CASH
CASH
CLB
CLB
Q1 26
3.7%
Q4 25
60.1%
3.6%
Q3 25
160.9%
4.8%
Q2 25
14.1%
8.0%
Q1 25
67.2%
3.1%
Q4 24
-40.4%
13.4%
Q3 24
77.3%
7.7%
Q2 24
58.8%
10.9%
Capex Intensity
CASH
CASH
CLB
CLB
Q1 26
Q4 25
2.4%
2.1%
Q3 25
1.8%
1.5%
Q2 25
1.4%
2.7%
Q1 25
1.3%
2.3%
Q4 24
1.1%
2.5%
Q3 24
2.4%
2.0%
Q2 24
1.2%
2.2%
Cash Conversion
CASH
CASH
CLB
CLB
Q1 26
5.12×
Q4 25
3.08×
1.61×
Q3 25
7.83×
0.60×
Q2 25
0.72×
1.31×
Q1 25
2.51×
Q4 24
-2.39×
2.78×
Q3 24
4.27×
1.12×
Q2 24
2.52×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Consumer$103.0M59%
Payment Card And Deposit Fees$30.1M17%
Other$24.2M14%
Rental Income$11.6M7%
Commercial$4.2M2%

CLB
CLB

Segment breakdown not available.

Related Comparisons